[Intermediate-dose cytosine arabinoside in combination with mitoxantrone in the treatment of refractory leukemia].
Takeyama
H
H
Fukutani
H
H
Takeo
T
T
Yamada
H
H
Watanabe
E
E
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage; D012074:Remission Induction
D003561:Cytarabine; D008942:Mitoxantrone